A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
Completed · Phase 3
Conditions studied: Migraine
In brief
The purpose of this study is to test an experimental drug combination of two medications currently approved by the Food and Drug Administration (FDA) for migraine headache or other pain. These are called rizatriptan given with acetaminophen.
Key facts
- Study ID
- NCT00300924
- Run by
- Diamond Headache Clinic
- People needed
- 200
- Starts
- 2006-03-01
- Expected to finish
- 2007-01-01
- Last updated by the study team
- 2008-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is at least 18 years of age
- Subject has at least a 6 month history of migraine, with or without aura
- Subject can distinguish between migraine attacks and other types of headaches
- Subject of childbearing potential agrees to use adequate contraception
You may not qualify if…
- Subject typically has fewer than 1 or greater than 6 migraine attacks per month
- Subject typically has greater than 10 headache days per month
- Subject has evidence of ischemic heart disease
- Subject has uncontrolled high blood pressure
- Subject has a history, within 1 year, or current evidence of drug or alcohol abuse
- This list is not all inclusive*
Where it is running
- SanFrancisco Headache Clinic — San Francisco, California, United States
- Diamond Headache Clinic — Chicago, Illinois, United States
- Westside Family Medical Center — Kalamazoo, Michigan, United States
- Clinvest — Springfield, Missouri, United States
- Mercy Health Research — St Louis, Missouri, United States
- Elkind Headache Center — Mount Vernon, New York, United States
- ClinExcel — West Chester, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.